| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 04/08/2009 | CN101405283A HIV inhibiting 5-amido substituted pyrimidines |
| 04/08/2009 | CN101405282A Aurora kinase modulators and method of use |
| 04/08/2009 | CN101405281A Inhibitors of the interaction between MDM2 and P53 |
| 04/08/2009 | CN101405275A Triazolone derivative |
| 04/08/2009 | CN101405270A Pyrazoles as 11-beta-HSD-1 |
| 04/08/2009 | CN101405269A Substituted 1-amino-4-phenyl-dihydroisoquinolines, method for the production thereof, use thereof as a medicament, and medicaments containing them |
| 04/08/2009 | CN101405268A Amide derivatives and their application for the treatment of g protein related diseases |
| 04/08/2009 | CN101405264A Piperidinyl, indolyl, pirinidyl, morpholinyl and benzimidazolyl urea derivatives as inhibitors of soluble epoxide hydrolase for the treatment of hypertension, inflammations and other diseases |
| 04/08/2009 | CN101405263A Cannibinoid receptor modulators |
| 04/08/2009 | CN101402645A Benzimidazolyl-acridine ligand CuI complex and method of preparing the same |
| 04/08/2009 | CN101402644A Production method for metal aza ring carbene complex |
| 04/08/2009 | CN101402598A Improved method for preparing 1-benzhydryl-3-aza ring butanol |
| 04/08/2009 | CN101402554A 2- and 2,5-substituted phenylketo-enols |
| 04/08/2009 | CN100475792C Novel gamma-secretase inhibitors |
| 04/08/2009 | CN100475778C Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient |
| 04/08/2009 | CN100475777C Amide type carboxamide derivative |
| 04/07/2009 | US7514570 Derivatives of 3-hydroxy-4-(cyclyl-alkylaminoalkyl)-5-phenyl-1h-pyrazole as antagonists of the gonadotropin releasing hormone (GnRH) for use in the treatment of sex hormone related conditions, such as prostatic of uterine cancer |
| 04/07/2009 | US7514565 3,5-Difluoropyridines |
| 04/07/2009 | US7514564 Substituted amine derivatives and methods of use |
| 04/07/2009 | US7514562 Urea derivatives and their use as vanilloid receptor antagonists in the treatment of pain |
| 04/07/2009 | US7514561 Pesticidal 5-(acylamino) pyrazole derivatives |
| 04/07/2009 | US7514560 Thermodynamically stable at room temperature, nonhygroscopic |
| 04/07/2009 | US7514558 e.g. 3-(4-{[6-({(2R)-2-hydroxy-2-[4-hydroxy-3-(hydroxymethyl)-phenyl]ethyl}amino)-hexyl]oxy}butyl)benzenesulfonamide; beta 2 adrenergic receptor agonist and muscarinic receptor antagonist activity; bronchodilator agent; pulmonary disorders: chronic obstructive pulmonary disease; asthma |
| 04/07/2009 | US7514475 Benzylamine analogues |
| 04/07/2009 | US7514467 Novel polymorphic form IV and solvate; precipitation from ethyl acetate |
| 04/07/2009 | US7514460 Benzazole analogues and uses thereof |
| 04/07/2009 | US7514458 Heterocyclic-substituted benzamide derivatives, e.g., benzyl [2-(4-{1-[5-(5-tert-Butyl-3-methanesulfonylamino-2-methoxy-phenylcarbamoyl)-2-methyl-phenyl]-1H-1,2,3-triazol-4-yl}-2-phenyl-2H-pyrazol-3-yl)-ethyl]-carbamate; inhibit production of cytokines; useful for treating chronic inflammatory disease |
| 04/07/2009 | US7514456 Nicotinamide derivatives useful as p38 inhibitors |
| 04/07/2009 | US7514451 1 -cyclopropyl-7- [3-cyclopropylaminomethyl-4-fluoro-1 -pyrrolidinyl]-6-fluoro -1 ,4-dihydro-8-methyl-4-oxo-3-quinolinecarboxylic acid; bactericide; against drug-resistant bacteria and against gram-positive bacteria, such as MRSA, PRSP and VRE |
| 04/07/2009 | US7514445 Heteroaryl amines as glycogen synthase kinase 3β inhibitors (GSK3 inhibitors) |
| 04/07/2009 | US7514440 angiogenesis inhibitors; as antitumor agents; kinase inhibitors like vascular endothelial growth factor receptors antagonists |
| 04/07/2009 | US7514438 Melanin concentrating hormone receptor antagonist |
| 04/07/2009 | US7514437 2-(2,4-difluorophenyl)-2-[(3R,6R)-3-(2,3-dihydro-1H-inden-2-yl)-6-isobutyl-2,5-dioxopiperazin-1-yl]-N,N-dimethylethanamide; to suppress uterine contractions; cyclization of leucine analogs |
| 04/07/2009 | US7514435 Pyrrolotriazine kinase inhibitors |
| 04/07/2009 | US7514433 1H-indole-6-yl-piperazin-1-yl-methanone derivatives |
| 04/07/2009 | US7514431 Piperidinyl cyclopentyl aryl benzylamide modulators of chemokine receptor activity |
| 04/07/2009 | US7514428 Pesticidal 1-aryl-3-amidoxime-pyrazole derivatives |
| 04/07/2009 | US7514424 schizophrenia, emesis, anxiety and depression, irritable bowel syndrome (IBS), circadian rhythm disturbances, visceral pain, neurogenic inflammation, asthma, micturition disorders such as urinary incontinence and nociception; reductive hydrogenation |
| 04/07/2009 | US7514409 VLA-4 antagonists |
| 04/07/2009 | US7514225 detecting drugs that inhibits the binding of macrophage migration inhibitory factor (MIF) to an antimacrophage migration inhibitor factor monoclonal or polyclonal antibody; drug screening |
| 04/07/2009 | US7514068 Biphenyl-pyrazolecarboxamide compounds |
| 04/07/2009 | CA2415890C N-oxides as nk1 receptor antagonist prodrugs of 4-phenyl-pyridine derivatives |
| 04/07/2009 | CA2400554C Pyrimidine-4-one derivatives as ldl-pla2 inhibitors |
| 04/07/2009 | CA2393757C Cycloamine ccr5 receptor antagonists |
| 04/07/2009 | CA2373880C Isoquinoline derivatives or salts thereof |
| 04/07/2009 | CA2361998C Aromatic heterocyclic compounds as anti-inflammatory agents |
| 04/02/2009 | WO2009042907A1 Isoindoline compounds for the treatment of spinal muscular atrophy and other uses |
| 04/02/2009 | WO2009042485A1 Indole compounds bearing aryl or heteroaryl groups having sphingosine-1-phosphate (s1p) receptor biological activity |
| 04/02/2009 | WO2009042200A1 Solid forms comprising 3-(2,5-dimethyl-4-oxo-4h-quinazolin-3-yl)-piperidine-2,6-dione, compositions comprising the same, and methods of using the same |
| 04/02/2009 | WO2009042177A1 6-, 7-, or 8-substituted quinazolinone derivatives and compositions comprising and methods of using the same |
| 04/02/2009 | WO2009041904A1 Quinoline compounds having an activity against the gabab receptor |
| 04/02/2009 | WO2009041789A2 Novel 3-chloro-5-substituted-quinoxaline-2-amine derivatives and pharmaceutically acceptable salt thereof, method for preparation, therapeutic agent for inflammatory disease induced by spc activity containing 3-chloro-5-substituted-quinoxaline-2-amine derivatives as an effective ingredient |
| 04/02/2009 | WO2009041567A1 Diaryl ketimine derivative having antagonistic activity on melanin-concentrating hormone receptor |
| 04/02/2009 | WO2009041566A1 Preventive or remedy for posterior eye diseases containing quinazolinone derivative or quinoxaline derivative as the active ingredient |
| 04/02/2009 | WO2009041565A1 Quinazolinone derivative, and prophylactic or therapeutic agent for corneal/conjunctival disorder comprising quinazolinone derivative as active ingredient |
| 04/02/2009 | WO2009041559A1 Indazole acrylic acid amide compound |
| 04/02/2009 | WO2009041521A1 Quinolone derivative |
| 04/02/2009 | WO2009041475A1 Method for producing pyrazol-3-yl-benzamide derivative |
| 04/02/2009 | WO2009040825A1 A process for preparation of enantiomerically pure esomeprazole |
| 04/02/2009 | WO2009040399A1 Substituted pyrrolo-pyrimidine derivatives, process for their preparation and their use as kinase inhibitors |
| 04/02/2009 | WO2009040290A1 Quinoline derivatives as 5ht5a receptor antagonists |
| 04/02/2009 | WO2009040288A1 1,1,1-trifluoro-2-hydroxy-3-phenylpropane derivatives |
| 04/02/2009 | WO2009039859A1 Ring-substituted phenyl pyrrole aminoguanidine derivatives |
| 04/02/2009 | WO2009039635A1 Methods of modulating neurotrophin-mediated activity |
| 04/02/2009 | WO2009019469A3 Pyrrolidines as catalyst compounds |
| 04/02/2009 | WO2009016227A3 Novel compounds |
| 04/02/2009 | WO2009014910A3 N-azacyclic substituted pyrrole, pyrazole, imidazole, triazole and tetrazole derivatives as agonists of the rup3 or gpr119 receptor for the treatment of diabetes and metabolic disorders |
| 04/02/2009 | WO2009011880A3 Heterocyclic modulators of pkb |
| 04/02/2009 | WO2009010299A8 Substituted heteroarylpiperidine derivatives as melanocortin-4 receptor modulators |
| 04/02/2009 | WO2009009501A3 Non-basic melanin concentrating hormone receptor-1 antagonists and methods |
| 04/02/2009 | WO2008156832A3 Renin inhibitors |
| 04/02/2009 | WO2007103711A3 Polymorphic forms of rimonabant |
| 04/02/2009 | US20090088570 Organic electroluminescent device |
| 04/02/2009 | US20090088457 Primary Amines as Renin Inhibitors |
| 04/02/2009 | US20090088456 2-Pyridinylethylcarboxamide derivatives and their use as Fugicides |
| 04/02/2009 | US20090088453 such as biphenyl-2-yl-carbamic acid 1- {2-[5-(4-carbamoylpiperidin-l-ylmethyl)thiophen-2-ylcarbamoyl]ethyl}piperidin-4-yl ester for treating pulmonary disorders (asthma, chronic obstructive pulmonary disease); anticholinergic agents; reduced side effects such as dry mouth and constipation |
| 04/02/2009 | US20090088452 Indole Orexin Receptor Antagonists |
| 04/02/2009 | US20090088450 5-ht7 receptor antagonists |
| 04/02/2009 | US20090088441 Quinoline Compounds |
| 04/02/2009 | US20090088430 hydroxysteroid reductase inhibitors such as 4-{(R)-3-[3,5-Dichloro-4'-(4-trifluoromethyl-piperidine-1-carbonyl)-biphenyl-4-ylmethyl]-2-oxo-pyrrolidin-1-yl}-piperidine-1-carboxylic acid methyl ester, used for treating diabetes, hyperglycemia, obesity, hypertension, hyperlipidemia and metabolic syndrome |
| 04/02/2009 | US20090088429 Isoquinoline Derivatives |
| 04/02/2009 | US20090088428 (R)-3-(3,5-Dichloro-4'-morpholin-4-yl-biphenyl-4-ylmethyl)-1-(4,5,6,7-tetrahydro-1H-benzoimidazol-5-yl)-pyrrolidin-2-one for treating diabetes, hyperglycemia, obesity, hypertension, hyperlipidemia, metabolic syndrome |
| 04/02/2009 | US20090088422 4-imidazolin-2-one compounds |
| 04/02/2009 | US20090088420 Compounds with hiv-1 integrase inhibitory activity and use thereof as anti-hiv/aids therapeutics |
| 04/02/2009 | US20090088419 Pyridyl acetic acid compounds |
| 04/02/2009 | US20090087409 Viral Polymerase Inhibitors |
| 04/02/2009 | US20090085468 Aromatic amine derivatives and organic electroluminescence devices using the same |
| 04/02/2009 | DE19959619B4 Sterisch gehinderte Aminverbindungen und damit stabilisierte organische Materialien Sterically hindered amine compounds and organic materials stabilized therewith |
| 04/02/2009 | CA2704710A1 6-, 7-, or 8-substituted quinazolinone derivatives and compositions comprising and methods of using the same |
| 04/02/2009 | CA2700936A1 Production method for pyrazol-3-yl-benzamide derivative |
| 04/02/2009 | CA2700841A1 Isoindoline compounds for the treatment of spinal muscular atrophy and other uses |
| 04/02/2009 | CA2700539A1 Indole compounds bearing aryl or heteroaryl groups having sphingosine-1-phosphate (s1p) receptor biological activity |
| 04/02/2009 | CA2700277A1 1,1,1-trifluoro-2-hydroxy-3-phenylpropane derivatives |
| 04/02/2009 | CA2700113A1 Indazole acrylic acid amide compound |
| 04/02/2009 | CA2700088A1 Quinolone derivative |
| 04/02/2009 | CA2699697A1 Quinoline derivatives as 5ht5a receptor antagonists |
| 04/01/2009 | EP2042490A2 Benzimidazole derivatives as vanilloid receptor antagonists |
| 04/01/2009 | EP2042171A1 Therapeutic or prophylactic agent for allergic dermatitis |
| 04/01/2009 | EP2041118A1 Substituted heterocyclic compounds and methods of use |
| 04/01/2009 | EP2041117A1 Heterocyclic substituted piperazine compounds with cxcr3 antagonist activity |